Fast-Clearable Nanocarriers Conducting Chemo/Photothermal Combination Therapy to Inhibit Recurrence of Malignant Tumors
Fast-Clearable Nanocarriers Conducting Chemo/Photothermal Combination Therapy to Inhibit Recurrence of Malignant Tumors
复制标题
快速清除纳米载体进行化疗/光热联合疗法抑制恶性肿瘤复发
DOI:
10.1002/smll.201700963
复制
发表时间:
2017
期刊:
影响因子:
13.3
通讯作者:
Zhao Yanli
中科院分区:
文献类型:
--
作者:
Zhao Lingzhi;Yuan Wei;Huijun Phoebe Tham;Chen Hongzhong;Xing Pengyao;Xiang Huijing;Yao Xin;Qiu Xiaochen;Dai Yu;Zhu Liangliang;Li Fuyou;Zhao Yanli
Inhomogeneous heating by photothermal therapy (PTT) during cancer treatment often results in the recurrence of tumors. Thus, integrating PTT with chemotherapy (CHT) may provide a complementary treatment for enhanced therapeutic efficiency. Herein, this study develops a hollow structured polymer–silica nanohybrid (HPSN) as a nanocarrier to simultaneously deliver the anticancer drug paclitaxel and photothermal agent palladium phthalocyanine to tumors through enhanced permeation and the retention effect. A combinational CHT/PTT therapy on mice bearing aggressive tumor grafts is conducted. The highly malignant tumor model, which recurs after sole treatment of PTT, can be eradicated by the combined CHT/PTT treatment. In addition, most of the off‐targeted HPSN nanocarriers can be excreted through a hepatobiliary pathway in about 10 d. Serology results show that the fast‐clearable HPSN can significantly reduce the side effect of the loaded paclitaxel drug. The present work provides an alternative approach for combinational cancer treatment with high therapeutic efficiency.